About the Fund
To provide high relative investment growth over the long term by investing in international shares, which exceed the Fund’s performance benchmark after costs and before tax.
To provide total returns (income and capital growth) after costs and before tax, above the Fund's performance benchmark on a rolling 3 year basis.
This product is likely to be appropriate for a consumer seeking capital growth to be used as a satellite/core holding within a portfolio where the consumer has a medium to long investment timeframe and a very high risk/return profile.
Withdrawals are allowed daily. Withdrawals are normally processed within 5 business days. The constitution allows for payments to be made within 30 calendar days.
What are the risks?
The Fund may be suitable for a consumer with a more aggressive or very high-risk appetite, seeking to maximise returns and can accept higher potential losses (eg has the ability to bear more than 6 negative returns over a 20-year period (SRM 7)) in order to target a higher return.
The ‘Risks of investing’ section of the Product Disclosure Statement and Incorporated Information for this Fund provides further information about the risks noted above, as well as information about other investment risks of which you should be aware.
For more detailed information relating to the risks of the fund, please refer to the relevant Product Disclosure Statement.
Investment Partners
American Century Investments
American Century Investments is a leading global asset manager focused on delivering investment results and building long-term client relationships while supporting breakthrough medical research. Founded in 1958, American Century Investments' 1,400 employees serve institutions, corporations and individual investors from offices in Kansas City; New York; Los Angeles; Santa Clara; Portland; London; Frankfurt; Hong Kong; and Sydney.
Arrowstreet Capital, Limited Partnership
Arrowstreet Capital, Limited Partnership is an investment firm that manages global equity portfolios for institutional investors around the world. Founded in June 1999, our investment process seeks to outperform broad equity benchmarks through a risk-controlled core approach. We combine sound investment intuition and research with quantitative tools to identify mispriced stocks around the world.
GQG Partners
GQG Partners, launched in 2016, is a boutique investment firm focused on long-only global, US and emerging markets equity strategies. GQG Partners is a wholly owned subsidiary of GQG Partners Inc, a Delaware corporation that is listed on the Australian Securities Exchange.
Registered trademark of Orbis Holdings Limited used under licence
Orbis Investments
Orbis has been confidently investing in undervalued and ignored global stocks for over 30 years. Their international team of 60+ investment professionals concentrate on unearthing companies trading for less than they are worth, rather than timing market trends. Orbis has applied the same fundamental, long-term and contrarian investment approach to investing since its inception.
Vinva
Vinva is an independent investment management firm established in 2010. Vinva specialises in managing active equity strategies including long-only, long-short and market neutral strategies across Australia and global equity markets.
View our pricing and performance page for more information
Platform Fund
Fund details
| APIR code | AMP0824AU |
| Minimum investment |
$10,000,000 |
| Investment objective |
To provide total returns (income and capital growth) after costs and before tax, above the Fund's performance benchmark on a rolling 3 year basis. The benchmark for the Fund is the MSCI World ex Australia ex Tobacco Index (net dividend reinvested). |
| Investment approach |
The Fund normally invests in international shares. |
| Minimum suggested timeframe |
7 years |
| Distribution frequency |
Half-yearly |
| Product inception date | 05 Feb 2004 |
| Risk level (1-7) | 7. Very High |
| Product status | Open |
Documents & Downloads
PDS Updates
We're here to help
AMP Investments
Mon - Fri: 8.30am – 5pm (AEST)
What you need to know
This information has been prepared by National Mutual Funds Management Ltd (ABN 32 006 787 720, AFSL 234652) (NMFM). This information is solely for the use of the party to whom it is provided and must not be provided to any other person or entity without the express written consent of NMFM.
While every care has been taken in the preparation of this information, NMFM makes no representation or warranty as to the accuracy or completeness of any statement in it including without limitation, any forecasts. This information has been prepared for the purpose of providing general information, without taking account of any particular investor’s objectives, financial situation or needs. Investors should, before making any investment decisions, consider the appropriateness of the information in this information, and seek professional advice, having regard to their objectives, financial situation and needs.
The investment option referred to on this page is available through products issued by N.M. Superannuation Proprietary Ltd ABN 31 008 428 322, AFSL 234654 (NM Super)..
Neither NM Super, NMFM nor any other company in the AMP Group guarantees the repayment of capital or the performance of any product or any particular rate of return referred to in this information. Past performance is not a reliable indicator of future performance. All information on this website is subject to change without notice. NMFM is part of the AMP group.
The information included on this page was current on the date published within the document or report and issued by the entity identified in the document or report. For up-to-date information, we refer you to the relevant product disclosure statement, target market determination and product updates available at amp.com.au.